Development of Molecular Genetic Interventions for HIV Infection
dc.contributor.author | Woffendin, Clive | |
dc.contributor.author | Ranga, Udaykumar | |
dc.contributor.author | Nabel, Gary J. | |
dc.date.accessioned | 2020-01-13T15:07:50Z | |
dc.date.available | 2020-01-13T15:07:50Z | |
dc.date.issued | 1997-02 | |
dc.identifier.citation | Woffendin, Clive; Ranga, Udaykumar; Nabel, Gary J. (1997). "Development of Molecular Genetic Interventions for HIV Infection." Current Protocols in Human Genetics 12(1): 13.6.1-13.6.18. | |
dc.identifier.issn | 1934-8266 | |
dc.identifier.issn | 1934-8258 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/152699 | |
dc.description.abstract | This unit includes a set of protocols for the ex vivo transfer of genes into CD4+ T cells, to be used in the initial evaluation of genes protecting against HIV infection in gene therapy protocols. The describes isolating and expanding CD4+ T cells from the patient. The cells are then transduced by either retroviral transduction or particle‐mediated gene transfer and reinfused into the patient. To monitor the effectiveness of gene transfer, genomic DNA is prepared from the patient’s cells. Detection of vector DNA by PCR analysis of the patient’s genomic DNA following gene transfer is also described in detail. | |
dc.publisher | John Wiley & Sons | |
dc.title | Development of Molecular Genetic Interventions for HIV Infection | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Biological Chemistry | |
dc.subject.hlbsecondlevel | Genetics | |
dc.subject.hlbsecondlevel | Molecular, Cellular and Developmental Biology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.subject.hlbtoplevel | Science | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/152699/1/cphg1306.pdf | |
dc.identifier.doi | 10.1002/0471142905.hg1306s12 | |
dc.identifier.source | Current Protocols in Human Genetics | |
dc.identifier.citedreference | Leavitt, M.C., Yu, M., Yamada, O., Kraus, G., Looney, G., Poeschla, E., Wong‐Staal, F. 1994. Transfer of an anti‐HIV‐1 ribozyme gene into primary human lymphocytes. Hum. Gene Ther. 5(9): 1115 ‐ 1120. | |
dc.identifier.citedreference | Levine, L.L., Mosca, J.D., Riley, J.L., Carroll, R.G., Vahey, M.T., Jagodzinski, L.L., Wagner, K.F., Mayers, D.L., Burke, D.S., Weislow, O.S., St. Louis, D.C., and June, C.H. 1996. Antiviral effect and ex vivo CD4 T cell proliferation in HIV positive patients as a result of CD28 costimulation. Science 272: 1939 ‐ 1943. | |
dc.identifier.citedreference | Nabel, G.J., Gene therapy approaches to AIDS. 1994. AIDS 8 (suppl. 1): S61 ‐ 69. | |
dc.identifier.citedreference | Nabel, G.J., Fox, B.A., Post, L., Thompson, C.B., and Woffendin, C. 1994. A molecular genetic intervention for AIDS‐effects of a transdominant negative form of Rev. Hum. Gene Ther. 5: 79 ‐ 92. | |
dc.identifier.citedreference | Poli, G. and Fauci, A.S. 1993. General guidelines for experimenting with HIV. In Current Protocols in Immunology ( J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober, eds.)pp. 12.1.1 ‐ 12.1.7. John Wiley & Sons, New York. | |
dc.identifier.citedreference | Sanford, J.C., Smith, F. D., and Russell, J.A. 1993. Optimizing the biolistic process for different biological applications. Methods Enzymol. 217: 483 ‐ 509. | |
dc.identifier.citedreference | Strober, W. 1996. Obtaining human peripheral blood cells. In Current Protocols in Immunology ( J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober, eds.)pp. A.3.13 ‐ A.3.14. John Wiley & Sons, New York. | |
dc.identifier.citedreference | Woffendin, C., Yang, Z.Y., Ranga, U., Xu, L., Yang, N.S., Sheehy, M.J., and Nabel, G.J. 1994. Nonviral and viral delivery of HIV protective gene into primary T cells. Proc. Natl. Acad. Sci. U.S.A. 91: 11581 ‐ 11585. | |
dc.identifier.citedreference | Woffendin, C., Ranga, U., Yang, Z.Y., Xu, L., and Nabel, G.J. 1996. Expression of a protective gene prolongs survival of T cells in HIV infected patients. Proc. Natl. Acad. Sci. U.S.A. 93: 2889 ‐ 2894. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.